Top compounds associated with response to RIBC2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.12 0.001
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.11 0.001
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.097 0.002
mRNA paclitaxel CCLE pan-cancer AAC 0.15 0.002
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.1 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ML311 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.1 0.003
mRNA Topotecan CCLE pan-cancer AAC 0.13 0.003
Download CSV